Drugs / Kenalog 10
Regulatory milestones approvals, filings & regulatory actions · 1 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Approved | US (FDA) | KENALOG-10 | — | 1960-01-04 | fda.gov ↗ |
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01720056 Comparator | Oct 2012 → Mar 2014 | keloid | The University of Western Australia | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Kenalog 10 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01720056 ↗ |
| Route | Subcutaneous | “Kenalog 10 mg/mL injection sc intralesionally” NCT01720056 ↗ |